Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Study About the Effect of Preventive Adjacent Level Cement Augmentation After Osteoporotic Vertebral Compression Fractures [Phase 4]
Phase 4 trial update on preventive adjacent level cement augmentation after osteoporotic vertebral compression fractures was terminated.
-
FDA approval · 2023-03-08FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for zoledronic acid from Fresenius Kabi USA, LLC.
-
FDA approval · 2023-03-07FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for zoledronic acid submitted by Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Tocotrienols and Bone Health of Postmenopausal Women [Phase 1, Phase 2]
Clinical trial updates on tocotrienols for bone health in postmenopausal women have completed Phase 1 and Phase 2 studies for osteoporosis.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Denosumab vs Zoledronic Acid and Osteoporotic Compression Fracture [Phase 2, Phase 3]
Clinical trial comparing denosumab to zoledronic acid for osteoporotic compression fractures across Phase 2 and Phase 3.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-02-15FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for ibandronate sodium submitted by Bionpharma Inc. under ANDA078998.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: The Effect of Effervescent Alendronate on Bone Turnover [Phase 4]
Phase 4 trial update on effervescent alendronate's effect on bone turnover in osteopenia or osteoporosis.
-
FDA approval · 2023-01-31FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC for use as a generic product …
-
CLINICAL_TRIALS trial_result · 2023-01-19Clinical Trial Update: Bone Health in Aging HIV Infected Women [Phase 4]
This Phase 4 clinical trial update reports completion and results posting of a study on bone health in aging women with HIV, focusing on ost…
-
FDA approval · 2022-12-19FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)
FDA approved a supplemental application for TYMLOS (abaloparatide) submitted by Radius Health, Inc.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Osteoporosis in Primary Hyperparathyroidism [Phase 4]
Phase 4 clinical trial update investigating osteoporosis in the context of primary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density [Phase 2]
Phase 2 trial update evaluating multiple dosing regimens of BPS804 in postmenopausal women with low bone mineral density (osteopenia/osteopo…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate [Phase 3]
Phase 3 trial investigating effervescent calcium magnesium citrate to avert complications of long-term proton pump inhibitor therapy; study …
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women [Phase 4]
Phase 4 trial assessing effectiveness and safety of EuBone capsules for bone health in postmenopausal women with osteoporosis.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis [Phase 4]
Phase IV trial evaluating efficacy and safety of MASI BONE S (Alendronate Sodium Trihydrate) in postmenopausal women with osteoporosis is on…
-
FDA approval · 2022-04-05FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Zoledronic acid submitted by Sagent Pharmaceuticals, updating regulatory labeling per the su…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis [Phase 3]
Phase III clinical trial update for minodronate tablets in postmenopausal osteoporosis; status not specified.
-
FDA approval · 2022-02-22FDA Approved: IBANDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ibandronate sodium filed by Aurobindo Pharma Limited, approving the generic product under the AN…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) [Phase 3]
A long-term extension of the FIT fracture intervention trial (Phase 3) for osteoporosis in postmenopausal individuals has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468) [Phase 3]
Phase 3 clinical trial evaluating tibolone for osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion [Phase 4]
Phase 4 trial investigating denosumab's effects on bone fusion in osteoporotic patients after lumbar fusion.
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Selenium for Musculoskeletal Health [Phase 3]
Phase 3 clinical trial update on selenium for musculoskeletal health in osteoporosis patients has completed.
-
CLINICAL_TRIALS research · 2021-12-17Clinical Trial Update: Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa [Phase 4]
Phase 4 clinical trial investigating vitamin D status and bone metabolism in children with congenital epidermolysis bullosa.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Simvastatin to Prevent SCI-Induced Bone Loss [Phase 2]
Phase 2 clinical trial investigating simvastatin to prevent bone loss after spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Alendronate Versus Denosumab in Kidney Transplant Patients [Phase 2, Phase 3]
A randomized trial comparing alendronate to denosumab in kidney transplant recipients with osteoporosis or osteopenia has completed Phase 2/…